Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study

Natasha van Eijkelenburg; M Rasche; E Ghazaly; MN Dworzak; T Klingebiel; C Rossig; G Leverger; J Stary; E de Bont; Dana Chitu; Y Bertrand; B Brethon; B Strahm; Inge Sluis; GJL Kaspers; D Reinhardt; C.M. Zwaan

doi:10.3324/haematol.2017.187153

Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study

Natasha van Eijkelenburg, M Rasche, E Ghazaly, MN Dworzak, T Klingebiel, C Rossig, G Leverger, J Stary, E de Bont, Dana Chitu, Y Bertrand, B Brethon, B Strahm, Inge Sluis, GJL Kaspers, D Reinhardt, C.M. Zwaan

Research output: Contribution to journal › Article › Academic › peer-review

23 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1484-1492
Number of pages	9
Journal	Haematologica
Volume	103
Issue number	9
DOIs	https://doi.org/10.3324/haematol.2017.187153
Publication status	Published - 2018

Access to Document

10.3324/haematol.2017.187153

http://hdl.handle.net/1765/110188

Cite this

van Eijkelenburg, N., Rasche, M., Ghazaly, E., Dworzak, MN., Klingebiel, T., Rossig, C., Leverger, G., Stary, J., de Bont, E., Chitu, D., Bertrand, Y., Brethon, B., Strahm, B., Sluis, I., Kaspers, GJL., Reinhardt, D., & Zwaan, C. M. (2018). Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study. Haematologica, 103(9), 1484-1492. https://doi.org/10.3324/haematol.2017.187153

@article{467e8ac15f794d92ab9531d99b2253a1,

title = "Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study",

author = "{van Eijkelenburg}, Natasha and M Rasche and E Ghazaly and MN Dworzak and T Klingebiel and C Rossig and G Leverger and J Stary and {de Bont}, E and Dana Chitu and Y Bertrand and B Brethon and B Strahm and Inge Sluis and GJL Kaspers and D Reinhardt and C.M. Zwaan",

year = "2018",

doi = "10.3324/haematol.2017.187153",

language = "Undefined/Unknown",

volume = "103",

pages = "1484--1492",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "9",

}

van Eijkelenburg, N, Rasche, M, Ghazaly, E, Dworzak, MN, Klingebiel, T, Rossig, C, Leverger, G, Stary, J, de Bont, E, Chitu, D, Bertrand, Y, Brethon, B, Strahm, B, Sluis, I, Kaspers, GJL, Reinhardt, D & Zwaan, CM 2018, 'Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study', Haematologica, vol. 103, no. 9, pp. 1484-1492. https://doi.org/10.3324/haematol.2017.187153

TY - JOUR

T1 - Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study

AU - van Eijkelenburg, Natasha

AU - Rasche, M

AU - Ghazaly, E

AU - Dworzak, MN

AU - Klingebiel, T

AU - Rossig, C

AU - Leverger, G

AU - Stary, J

AU - de Bont, E

AU - Chitu, Dana

AU - Bertrand, Y

AU - Brethon, B

AU - Strahm, B

AU - Sluis, Inge

AU - Kaspers, GJL

AU - Reinhardt, D

AU - Zwaan, C.M.

PY - 2018

Y1 - 2018

U2 - 10.3324/haematol.2017.187153

DO - 10.3324/haematol.2017.187153

M3 - Article

SN - 0390-6078

VL - 103

SP - 1484

EP - 1492

JO - Haematologica

JF - Haematologica

IS - 9

ER -